Ad Hoc News

Tempus AI's Breakneck Rally Faces Its First Test: Can Fundamentals Keep Pace?

Tempus AI shares jump 38% in a week on Merck-Moderna sequencing contract and strong Q2 earnings, yet insider selling and a 31 ...

Tempus AI soars as Merck-Moderna cancer trial validates Personalis acquisition

Shares of Tempus AI Inc TEM are surging Wednesday morning as traders connected the dots between a landmark clinical trial win ...

Tempus AI stock climbs Friday: What's driving the move?

Tempus AI Inc. TEM shares are trading higher on Friday as traders continue to digest the latest follow-through from this week ...
Yahoo Finance

Tempus Selected by ARPA-H to Provide CRO and Testing Services for the ADAPT Program, Advancing Precision Cancer Therapy

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Morningstar

Tempus Launches the PRECISION Challenge, a National Program Opening Its Foundation Model Work to the Broader Research Community

Inaugural program provides unprecedented access to Tempus’ library of de-identified multimodal data and models, scalable compute infrastructure and direct funding to catalyze clinical and technical ...
Nasdaq

Tempus Introduces Fuses, A Program Designed to Transform Therapeutic Research and Build the Largest Diagnostic Platform Using its Novel Foundation Model

The initiative will apply its massive, multimodal dataset to build models that aim to improve diagnostic, prognostic, and predictive modeling CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (NASDAQ: TEM), ...
AOL

Tempus Launches the PRECISION Challenge, a National Program Opening Its Foundation Model Work to the Broader Research Community

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the launch of the PRECISION Challenge, a national initiative engineered to ...